What is Immuron Ltd ADR?
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.26M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.